Viva Biotech Holdings's market cap is currently HK$3.41B. The company's EPS TTM is HK$-0.007; its P/E ratio is ―; Viva Biotech Holdings is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 2.16B	¥ 2.38B	¥ 2.10B	¥ 696.96M	¥ 323.06M
Gross Profit	¥ 738.43M	¥ 815.68M	¥ 650.98M	¥ 304.87M	¥ 155.87M
Operating Income	¥ 192.68M	¥ 265.98M	¥ 236.90M	¥ 112.54M	¥ 54.32M
EBITDA	¥ 391.01M	¥ -89.04M	¥ 369.94M	¥ -223.89M	¥ 70.78M
Net Income	¥ -116.11M	¥ -528.48M	¥ 287.55M	¥ -386.88M	¥ 265.87M
Balance Sheet
Cash & Short-Term Investments	¥ 1.04B	¥ 678.57M	¥ 800.95M	¥ 2.36B	¥ 933.72M
Total Assets	¥ 7.45B	¥ 7.92B	¥ 8.04B	¥ 8.15B	¥ 1.90B
Total Debt	¥ 1.90B	¥ 2.82B	¥ 2.65B	¥ 2.97B	¥ 49.41M
Net Debt	¥ 866.89M	¥ 2.14B	¥ 1.85B	¥ 661.06M	¥ -854.68M
Total Liabilities	¥ 3.76B	¥ 4.32B	¥ 4.13B	¥ 4.40B	¥ 121.39M
Stockholders' Equity	¥ 3.69B	¥ 3.60B	¥ 3.91B	¥ 3.76B	¥ 1.78B
Cash Flow
Free Cash Flow	¥ 195.57M	¥ 136.72M	¥ -487.35M	¥ -549.44M	¥ -10.18M
Operating Cash Flow	¥ 383.40M	¥ 386.05M	¥ 77.83M	¥ 43.18M	¥ 46.01M
Investing Cash Flow	¥ 439.17M	¥ -372.80M	¥ -868.84M	¥ -3.85B	¥ -290.06M
Financing Cash Flow	¥ -429.50M	¥ -143.20M	¥ -653.16M	¥ 5.31B	¥ 984.86M

Currency in CNY

Viva Biotech Holdings Earnings and Revenue History

Income Statement >

Viva Biotech Holdings Debt to Assets

Balance Sheet >

Viva Biotech Holdings Cash Flow

Cash Flow >

Viva Biotech Holdings Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing